Literature DB >> 7668123

Proliferative activity of acoustic neurilemomas without neurofibromatosis determined by monoclonal antibody MIB 1.

P H Aguiar1, M Tatagiba, E Dankoweit-Timpe, C Matthies, M Samii, H Ostertag.   

Abstract

Microscopic sections obtained from paraffin blocks of 30 consecutive neurilemomas stored in 1989 were investigated immunohistochemically with the new monoclonal antibody MIB 1 directed against recombinant parts of Ki-67 antigen. The immunohistochemical staining was carried out on dewaxed microwave-oven-processed paraffin sections of formalin-fixed tumour tissues. The labelling index (LI) obtained was below 1% in 21 cases, 1-3% in 7 cases and more than 3% in 2 cases. There was no correlation between the LI and the age of the patients or the tumour size. The major advantage of MIB 1 over previous immunohistochemical methods is its usefulness in long preserved sections which are ideal for retrospective studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7668123     DOI: 10.1007/bf01428499

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

1.  Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues.

Authors:  J Gerdes; M H Becker; G Key; G Cattoretti
Journal:  J Pathol       Date:  1992-09       Impact factor: 7.996

2.  Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody ki-67.

Authors:  T H Lesser; R C Janzer; P Kleihues; U Fisch
Journal:  Skull Base Surg       Date:  1991

3.  The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.

Authors:  P C Burger; T Shibata; P Kleihues
Journal:  Am J Surg Pathol       Date:  1986-09       Impact factor: 6.394

4.  Sex hormone receptors in acoustic neuromas.

Authors:  T J Siglock; S S Rosenblatt; F Finck; W F House; W E Hitselberger
Journal:  Am J Otol       Date:  1990-07

5.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

6.  Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors.

Authors:  T Nishizaki; T Orita; Y Furutani; Y Ikeyama; H Aoki; K Sasaki
Journal:  J Neurosurg       Date:  1989-03       Impact factor: 5.115

7.  S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine.

Authors:  T Hoshino; T Nagashima; K G Cho; J A Murovic; J E Hodes; C B Wilson; M S Edwards; L H Pitts
Journal:  Int J Cancer       Date:  1986-09-15       Impact factor: 7.396

8.  Immunohistochemical determination of protein kinase C expression and proliferative activity in human brain tumors.

Authors:  G Reifenberger; M Deckert; W Wechsler
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Acoustic neurinoma in the elderly: factors predictive of postoperative outcome.

Authors:  M Samii; M Tatagiba; C Matthies
Journal:  Neurosurgery       Date:  1992-10       Impact factor: 4.654

10.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

View more
  5 in total

1.  Aggressive vestibular schwannomas showing postoperative rapid growth - their association with decreased p27 expression.

Authors:  Ho Jun Seol; Hee-Won Jung; Sung-Hye Park; Sung-Kyun Hwang; Dong Gyu Kim; Sun Ha Paek; Young-Seob Chung; Chang Sub Lee
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

2.  BDNF mRNA expression is significantly upregulated in vestibular schwannomas and correlates with proliferative activity.

Authors:  Frauke Kramer; Timo Stöver; Athanasia Warnecke; Marc Diensthuber; Thomas Lenarz; Kirsten Wissel
Journal:  J Neurooncol       Date:  2009-11-25       Impact factor: 4.130

3.  Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics.

Authors:  Paulo Henrique Aguiar; Ana Maria Tsanaclis; Oswaldo Inácio Tella; José Pindaro Plese
Journal:  Neurosurg Rev       Date:  2003-04-08       Impact factor: 3.042

4.  The comparison between the growth fraction of bilateral vestibular schwannomas in neurofibromatosis 2 (NF2) and unilateral vestibular schwannomas using the monoclonal antibody MIB 1.

Authors:  P H Aguiar; M Tatagiba; M Samii; E Dankoweit-Timpe; H Ostertag
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

5.  The behavior of residual tumors following incomplete surgical resection for vestibular schwannomas.

Authors:  Hun Ho Park; So Hee Park; Hyeong-Cheol Oh; Hyun-Ho Jung; Jong Hee Chang; Kyu-Sung Lee; Won Seok Chang; Chang-Ki Hong
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.